BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 34360626)

  • 1. Reversing the Psychiatric Effects of Neurodevelopmental Cannabinoid Exposure: Exploring Pharmacotherapeutic Interventions for Symptom Improvement.
    De Felice M; Laviolette SR
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. l-Theanine Prevents Long-Term Affective and Cognitive Side Effects of Adolescent Δ-9-Tetrahydrocannabinol Exposure and Blocks Associated Molecular and Neuronal Abnormalities in the Mesocorticolimbic Circuitry.
    De Felice M; Renard J; Hudson R; Szkudlarek HJ; Pereira BJ; Schmid S; Rushlow WJ; Laviolette SR
    J Neurosci; 2021 Jan; 41(4):739-750. PubMed ID: 33268546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BDNF overexpression prevents cognitive deficit elicited by adolescent cannabis exposure and host susceptibility interaction.
    Segal-Gavish H; Gazit N; Barhum Y; Ben-Zur T; Taler M; Hornfeld SH; Gil-Ad I; Weizman A; Slutsky I; Niwa M; Kamiya A; Sawa A; Offen D; Barzilay R
    Hum Mol Genet; 2017 Jul; 26(13):2462-2471. PubMed ID: 28402427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects in rats of adolescent exposure to cannabis smoke or THC on emotional behavior and cognitive function in adulthood.
    Bruijnzeel AW; Knight P; Panunzio S; Xue S; Bruner MM; Wall SC; Pompilus M; Febo M; Setlow B
    Psychopharmacology (Berl); 2019 Sep; 236(9):2773-2784. PubMed ID: 31044291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the "two-hit hypothesis": Effects of prenatal maternal immune activation and adolescent cannabis use on neurodevelopment in mice.
    Guma E; Cupo L; Ma W; Gallino D; Moquin L; Gratton A; Devenyi GA; Chakravarty MM
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Jan; 120():110642. PubMed ID: 36150422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adolescent Δ
    Jouroukhin Y; Zhu X; Shevelkin AV; Hasegawa Y; Abazyan B; Saito A; Pevsner J; Kamiya A; Pletnikov MV
    Biol Psychiatry; 2019 Jun; 85(11):891-903. PubMed ID: 30219209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders.
    Krebs MO; Kebir O; Jay TM
    Eur J Pain; 2019 Aug; 23(7):1225-1233. PubMed ID: 30793421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal THC Exposure Induces Sex-Dependent Neuropsychiatric Endophenotypes in Offspring and Long-Term Disruptions in Fatty-Acid Signaling Pathways Directly in the Mesolimbic Circuitry.
    Sarikahya MH; Cousineau S; De Felice M; Lee K; Wong KK; DeVuono MV; Jung T; Rodríguez-Ruiz M; Ng THJ; Gummerson D; Proud E; Hardy DB; Yeung KK; Rushlow W; Laviolette SR
    eNeuro; 2022; 9(5):. PubMed ID: 36171057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What Can Rats Tell Us about Adolescent Cannabis Exposure? Insights from Preclinical Research.
    Renard J; Rushlow WJ; Laviolette SR
    Can J Psychiatry; 2016 Jun; 61(6):328-34. PubMed ID: 27254841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Relationship Between Cannabis, Cognition, and Schizophrenia: It's Complicated.
    Kayir H; Ruffolo J; McCunn P; Khokhar JY
    Curr Top Behav Neurosci; 2023; 63():437-461. PubMed ID: 36318403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis and synaptic reprogramming of the developing brain.
    Bara A; Ferland JN; Rompala G; Szutorisz H; Hurd YL
    Nat Rev Neurosci; 2021 Jul; 22(7):423-438. PubMed ID: 34021274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical marijuana: review of the science and implications for developmental-behavioral pediatric practice.
    Hadland SE; Knight JR; Harris SK
    J Dev Behav Pediatr; 2015; 36(2):115-23. PubMed ID: 25650954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal evidence considered in determination of cannabis smoke and Δ
    Niknam Y; Iyer P; Campbell MA; Moran F; Sandy MS; Zeise L
    Birth Defects Res; 2022 Nov; 114(18):1169-1185. PubMed ID: 36125082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical toxicology of cannabis.
    Schep LJ; Slaughter RJ; Glue P; Gee P
    N Z Med J; 2020 Oct; 133(1523):96-103. PubMed ID: 33032307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergent Medical Illnesses Related to Cannabis Use.
    Randall K; Hayward K
    Mo Med; 2019; 116(3):226-228. PubMed ID: 31527946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal cannabis exposure - The "first hit" to the endocannabinoid system.
    Richardson KA; Hester AK; McLemore GL
    Neurotoxicol Teratol; 2016; 58():5-14. PubMed ID: 27567698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effects of cannabinoids on addiction endophenotypes are moderated by genes encoding the CB1 receptor and FAAH enzyme.
    Hindocha C; Freeman TP; Schafer G; Gardner C; Bloomfield MAP; Bramon E; Morgan CJA; Curran HV
    Addict Biol; 2020 May; 25(3):e12762. PubMed ID: 31013550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
    Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
    Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guanfacine Attenuates Adverse Effects of Dronabinol (THC) on Working Memory in Adolescent-Onset Heavy Cannabis Users: A Pilot Study.
    Mathai DS; Holst M; Rodgman C; Haile CN; Keller J; Hussain MZ; Kosten TR; Newton TF; Verrico CD
    J Neuropsychiatry Clin Neurosci; 2018; 30(1):66-76. PubMed ID: 28641496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal Cannabinoid Exposure: Emerging Evidence of Physiological and Neuropsychiatric Abnormalities.
    Nashed MG; Hardy DB; Laviolette SR
    Front Psychiatry; 2020; 11():624275. PubMed ID: 33519564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.